Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spirulina Derivative for Preventing Radiation-Induced Esophagitis in Esophageal Cancer
NCT07324018Phase 2Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jan 2026
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in radiation-induced esophagitis (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Incidence of grade >=2 radiation-induced esophagitis (RTOG criteria). Planned start Jan 2026; status: not yet recruiting.
02
Conditions
radiation-induced esophagitis
Beyond the preview
Go deeper on NCT07324018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07324018.